CAS 462-06-6 - Factory, Suppliers, Manufacturers from China

CAS 462-06-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%
Read More

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Related Blog
Reviews

New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.11.29 22:41:45
2022.09.14 14:14:40
2022.06.14 10:24:17
2022.04.10 14:28:16
2022.01.27 16:02:52
2021.11.02 17:17:27

CAS 462-06-6 - Factory, Suppliers, Manufacturers from China

Related Products

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

Top Selling Products

Fmoc-His(Trt)-OPfp CAS 109434-24-4 Assay Purity >97.0% (HPLC)

Trityl Candesartan Cilexetil CAS 170791-09-0 Purity >98.0% (HPLC) Factory

Thiourea Dioxide CAS 1758-73-2 Purity ≥99.0%

3-Iodothiophene CAS 10486-61-0 Purity >98.0% (GC) Factory High Quality

Imidazole-2-Carboxaldehyde CAS 10111-08-7 Purity ≥99.0% (HPLC) Factory Main Product

TAPS CAS 29915-38-6 Purity >99.5% (Titration) Biological Buffer Ultra Pure Grade Factory

(S)-(-)-α-Methylbenzyl Isocyanate CAS 14649-03-7 Purity >99.0% (GC) Factory

Boc-Glu(OcHex)-OH CAS 73821-97-3 Purity >98.0% (HPLC) Factory

Argatroban Monohydrate CAS 141396-28-3 Purity ≥99.0% API Factory High Purity

L-4,4'-Biphenylalanine CAS 155760-02-4 (H-Bip-OH) Purity >98.0% (HPLC) e.e >98.0%

Boc-D-Arg-OH·HCl·H2O CAS 114622-81-0 Purity >99.0% (HPLC)

3-Bromobenzyl Cyanide CAS 31938-07-5 Purity >98.0% (GC)

New COVID treatments offer hope

Xi presents award to top scientists

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.11.29 22:41:45

2022.09.14 14:14:40

2022.06.14 10:24:17

2022.04.10 14:28:16

2022.01.27 16:02:52

2021.11.02 17:17:27

related search